Unknown

Dataset Information

0

Development of a Smart Scaffold for Sequential Cancer Chemotherapy and Tissue Engineering.


ABSTRACT: The fabrication of a dual-functional drug-containing porous polymeric scaffold by layer-by-layer surface modification involving citrate-stabilized gold nanoparticles and cisplatin molecules is being reported. These scaffolds were characterized by electron microscopy and X-ray photoelectron spectroscopy. The capability of the scaffolds to release hydrated cisplatin in a slow and sustained manner over two days is established. Most importantly, the scaffolds turn nontoxic and cell-friendly after drug release, thus allowing the noncancerous fibroblast cells to adhere and proliferate (from 5000 cells to 16,000 cells in 6 days), becoming a potential solution toward an effective drug-carrying scaffold for volume-filling applications. The scaffold-mediated cancer cell killing and fibroblast cell proliferation were confirmed by fluorescence microscopy imaging, flow cytometry, and cell proliferation assays. We surmise that such a dual-purpose (drug-delivery and volume-filler) scaffold could help avoid the multiple surgical interventions needed for tumor surgery and cosmetic corrections. To the best of our knowledge, this is the first example of scaffolds with such a dual functionality which gets manifested in a sequential manner.

SUBMITTER: Sengupta P 

PROVIDER: S-EPMC7450502 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Development of a Smart Scaffold for Sequential Cancer Chemotherapy and Tissue Engineering.

Sengupta Poulomi P   Agrawal Vinay V   Prasad Bhagavatula L V BLV  

ACS omega 20200811 33


The fabrication of a dual-functional drug-containing porous polymeric scaffold by layer-by-layer surface modification involving citrate-stabilized gold nanoparticles and cisplatin molecules is being reported. These scaffolds were characterized by electron microscopy and X-ray photoelectron spectroscopy. The capability of the scaffolds to release hydrated cisplatin in a slow and sustained manner over two days is established. Most importantly, the scaffolds turn nontoxic and cell-friendly after dr  ...[more]

Similar Datasets

| S-EPMC5503070 | biostudies-other
| S-EPMC9012216 | biostudies-literature
| S-EPMC8474106 | biostudies-literature
| S-EPMC5432418 | biostudies-literature
| S-EPMC4828277 | biostudies-literature
| S-EPMC2748110 | biostudies-literature
| S-EPMC6495184 | biostudies-literature
| S-EPMC8787149 | biostudies-literature
| S-EPMC3644393 | biostudies-literature
| S-EPMC7022784 | biostudies-literature